Table 5.
Univariable and multivariable analysis of OS in patients with NA therapy.
| Variables | Univariable analysis | Multivariable analysis | |
|---|---|---|---|
| P value | HR (95% CI) | P value | |
| VR (yes/no) | <0.001 | 0.772 (0.615-0.916) | 0.003 |
| Age, y (≤60/>60) | 0.308 | ||
| Sex (Male/Female) | 0.932 | ||
| Cirrhosis (yes/no) | 0.872 | ||
| Ascites (yes/no) | 0.182 | ||
| Splenomegaly (yes/no) | 0.017 | 1.222 (1.047-1.426) | 0.011 |
| ICGR 15 (≤10%/>10%) | 0.457 | ||
| Tumor capsule (yes/no) | 0.164 | ||
|
Up-to-seven criteria
(within/beyond) |
0.001 | ||
| AFP (≤20/>20) | 0.036 | ||
| GGT, u/L (≤50/>50) | 0.950 | ||
| AST, u/L (≤40/>40) | 0.740 | ||
| ALT, u/L (≤40/>40) | 0.988 | ||
| Albumin, g/L (≤30/>30) | 0.950 | ||
| TBIL, umol/L (≤20.5/>20.5) | 0.164 | ||
| PT, sec (≤14/>14) | 0.096 | ||
| WBC, 109/L (≤4/>4) | 0.438 | ||
| HB, g/L (≤120/>120) | 0.341 | ||
| Platelet count, 109/L (≤100/>100) | 0.001 | 1.277 (1.095-1.490) | 0.002 |